#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7762	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2365	631.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1565	1565	C	1007	C,G,A	640,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7762	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2365	631.1	0	HET	.	.	.	A69G,C	.	69	69	A	450	450	A	762	A,G,C	279,211,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14906	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3851	721.1	0	.	n	.	0	T695C	SNP	695	695	T	1198	1198	C	1084	C,A	669,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14906	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3851	721.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1840	1840	A	829	A,G	555,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14906	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3851	721.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2474	2474	C	787	C,A,T	521,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14906	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3851	721.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2548	2548	A	873	A,C	587,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14906	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3851	721.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3100	3100	C	888	C,T,A	450,132,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	616	folP	855	855	100.0	folP.l6.c4.ctg.1	1729	70.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1204	1206	AGC	110;110;111	A,G;G;C	77,1;79;80	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2050	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3313	117.0	1	SNP	p	S91F	1	.	.	271	273	TTC	620	622	TTC	143;145;145	T;T;C	92;93;96	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2050	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3313	117.0	1	SNP	p	D95G	1	.	.	283	285	GGC	632	634	GGC	166;168;169	G;G;C	104;106;105	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2050	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3313	117.0	1	SNP	p	G95N	0	.	.	283	285	GGC	632	634	GGC	166;168;169	G;G;C	104;106;105	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	564	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1451	75.7	1	SNP	p	G45D	0	.	.	133	135	GGC	387	389	GGC	150;150;150	G;G;C	95;94;93	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	354	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	902	73.1	0	.	n	.	0	A197.	DEL	197	197	A	483	483	A	128	A	82	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3263	99.1	1	SNP	p	D86N	0	.	.	256	258	GAC	693	695	GAC	163;162;161	G;A;C	101;97;103	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3263	99.1	1	SNP	p	R87W	0	.	.	259	261	CGT	696	698	CGT	160;159;161	C;G;T	101;96;102	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3263	99.1	1	SNP	p	S87R	1	.	.	259	261	CGT	696	698	CGT	160;159;161	C;G;T	101;96;102	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3263	99.1	1	SNP	p	R87I	0	.	.	259	261	CGT	696	698	CGT	160;159;161	C;G;T	101;96;102	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3263	99.1	1	SNP	p	S88P	0	.	.	262	264	TCC	699	701	TCC	162;164;163	T;C;C	103;105;106	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1406	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2539	103.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1496	1498	GGC	73;75;74	G;G;C,A	50;51;49,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1502	1504	GCA	183;183;182	G,T;C,A;A	120,1;120,1;120	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1505	1507	ATC	187;187;187	A;T,A;C	121;124,1;125	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1517	1519	GTG	187;187;188	G;T,A;G	122;122,1;126	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1517	1519	GTG	187;187;188	G;T,A;G	122;122,1;126	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2021	2023	ACC	113;114;114	A,C;C;C	67,1;75;79	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2075	2077	GCG	95;95;95	G;C;G	63;63;63	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2075	2077	GCG	95;95;95	G;C;G	63;63;63	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2198	2200	AGC	113;113;117	A,T;G;C	72,1;74;77	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2207	2209	GGC	108;108;107	G;G;C	69;69;66	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1532	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2593	110.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2225	2227	CCG	104;103;103	C,G;C,G;G	64,3;67,1;67	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2642	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3354	141.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1799	1801	CCG	110;110;110	C;C;G,C	78;81;77,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	834	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2225	73.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	702	702	C	84	C	49	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	339	341	AAT	11;11;11	A;A;T	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	342	344	AAT	11;11;9	A;A;T	9;9;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	366	368	GCA	7;8;8	G;C;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	389	391	GTA	8;8;8	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	S236N	NONSYN	706	708	AGC	395	397	AAC	8;8;8	A;A;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	N237M	NONSYN	709	711	AAC	398	400	ATG	8;8;8	A;T;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.7	porB1a.l15.c4.ctg.2	617	9.6	0	.	p	.	0	D238fs	FSHIFT	712	712	G	401	401	G	10	G	6	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	942	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1809	99.3	0	.	p	.	0	E48K	NONSYN	142	144	GAA	593	595	AAA	129;129;129	A;A;A	85;85;84	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	942	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1809	99.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1082	1082	T	117	T,G	86,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	942	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1809	99.3	1	SNP	p	G120K	0	.	.	358	360	GGT	809	811	GGT	101;102;100	G,T;G;T	69,1;71;69	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	942	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1809	99.3	1	SNP	p	A121D	0	.	.	361	363	GCC	812	814	GCC	103;102;102	G;C;C	72;72;73	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	942	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1809	99.3	1	SNP	p	A121N	0	.	.	361	363	GCC	812	814	GCC	103;102;102	G;C;C	72;72;73	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3400	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4642	138.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	270	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1097	51.5	1	SNP	p	V57M	1	.	.	169	171	ATG	567	569	ATG	121;116;117	A;T;G	80;76;78	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
